Ventilator-Associated Pneumonia (VAP) is a nosocomial
pneumonia that develops more than 48-72 hours after
endotracheal intubation.1 It is the most common infection
acquired by adults and children in intensive care units
(ICUs) and is a cause of significant patient morbidity and
mortality, increased utilization of healthcare resources and
excess cost.2 During mechanical ventilation, secretions
from the upper respiratory tract accumulate above the
endotracheal tube cuff. Studies have shown that these
secretions can seep past the cuff into the lower tract.3
Drainage of the subglottic secretions has been proven as an
effective strategy in preventing early-onset VAP.4
the clinical challenge.
The endotracheal tube chosen for initial intubation doesn’t
always allow for easy access to this valuable practice —
until now. That is why we created the new Teleflex ISIS
HVT with a separate suction line. The versatile design
eliminates the need to be selective during initial intubation,
increasing the number of patients who can be viable
candidates for post-operative subglottic suctioning, a
clinically proven strategy for VAP reduction.5